Article
Toenail selenium, plasma selenoprotein P and risk of advanced prostate cancer: A nested case-control study.
International journal of cancer - 15 Feb 2021
Outzen Malene, Tjønneland Anne, Hughes David J, Jenab Mazda, Frederiksen Kirsten, Schomburg Lutz, Morris Steve, Overvad Kim, Olsen Anja
Abstract excerpt
Low selenium status may be associated with increased risk of prostate cancer (PC), particularly aggressive PC, and variation in selenoprotein genes may constitute an important modifying factor. We aimed to investigate the association between two selenium status biomarkers [toenail selenium, plasma selenoprotein P (SELENOP)] and risk of advanced, high-grade and advanced-stage PC. We further studied whether...
Read the complete abstract on PubMedTopics
Share this publication in a Topic to start or enrich a Post.
